News from regado biosciences, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jan 06, 2009, 12:27 ET

Regado Biosciences To Present at the 27th Annual J.P. Morgan Healthcare Conference

Regado Biosciences, Inc. announced today that David J. Mazzo, Ph.D., President and Chief Executive Officer, will be presenting at the 27th Annual...

Dec 02, 2008, 07:30 ET

Ellen McDonald Joins Regado Biosciences as Senior Vice President of Business Operations and Chief Business Officer

Regado Biosciences, Inc., announced today the appointment of Ellen McDonald to the newly created position of Senior Vice President of Business...

Dec 01, 2008, 07:30 ET

Regado Biosciences to Present at the Piper Jaffray Health Care Conference on Tuesday, December 2, 2008

Regado Biosciences, Inc., announced today David J. Mazzo, Ph.D., President and Chief Executive Officer, will present at the 20th Annual Piper...

Nov 11, 2008, 07:30 ET

Alexander R. Giaquinto, Ph.D., Joins Regado Biosciences as Senior Vice President of Regulatory Affairs and Quality Assurance

Regado Biosciences, Inc., today announced the appointment of Alexander R. Giaquinto, Ph.D., to the newly created position of Senior Vice President...

Sep 02, 2008, 01:00 ET

Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008

MUNICH, Germany, Sept. 2 /PRNewswire/ -- Regado Biosciences, Inc. announced today the presentation of comprehensive results from Phase Ia, Ib...

Jun 05, 2008, 01:00 ET

Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System

DURHAM, N.C., June 5 /PRNewswire/ -- Regado Biosciences today announced the journal Circulation has published clinical data from the Company's...

May 14, 2008, 01:00 ET

Regado Biosciences' REG1 Anticoagulation System Study Results Published in the Journal of Thrombosis and Haemostasis

DURHAM, N.C., May 14 /PRNewswire/ -- Regado Biosciences today announced the Journal of Thrombosis and Haemostasis, the official journal of the...

Nov 19, 2007, 00:00 ET

Regado Biosciences to Present at 19th Annual Piper Jaffray Health Care Conference

DURHAM, N.C., Nov. 19 /PRNewswire/ -- Regado Biosciences today announced Doug Gooding, Regado's Chief Executive Officer, will present at the...

Nov 06, 2007, 00:00 ET

Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions

ORLANDO, Fla., Nov. 6 /PRNewswire/ -- Regado Biosciences today presented encouraging data from Phase Ia and Phase Ib dose escalation studies of...

Nov 04, 2007, 01:00 ET

Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions

ORLANDO, Fla., Nov. 4 /PRNewswire/ -- Regado Biosciences today presented data from a randomized, double-blind, placebo-controlled Phase Ic study...

Nov 01, 2007, 01:00 ET

Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System

DURHAM, N.C., Nov. 1 /PRNewswire/ -- Regado Biosciences today announced the enrollment of the first patient in a multi-center, open-label,...

Aug 15, 2005, 01:00 ET

Regado Biosciences Completes $20 Million Series B Financing

RESEARCH TRIANGLE PARK, N.C., Aug. 15 /PRNewswire/ -- Regado Biosciences, Inc., a drug development company focused on the development of...